Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Egg

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|September 26, 2018
Increased Risk for Malignancies in 131 Affected <i>CTLA4</i> Mutation CarriersDavid Egg, Charlotte Schwab, Annemarie Gabrysch, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2021
Therapeutic options for CTLA-4 insufficiencyDavid Egg, Ina Caroline Rump, Noriko Mitsuiki, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|September 26, 2018
Increased Risk for Malignancies in 131 Affected <i>CTLA4</i> Mutation CarriersDavid Egg, Charlotte Schwab, Annemarie Gabrysch, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2021
Therapeutic options for CTLA-4 insufficiencyDavid Egg, Ina Caroline Rump, Noriko Mitsuiki, et al.
Pageof 1